Lasik Eye Surgery Devices Market Size, Share, Growth Analysis, By Product Type(Excimer Lasers, Femtosecond Lasers, Microkeratomes and Others), By Application(Hospitals, Ambulatory Surgical Centers, Ophthalmology Clinics and Others), By End User(Adults and Pediatrics), By Region(North America, Europe, Asia-Pacific, Latin America), By Region - Industry Forecast 2024-2031

In March 2024, Contoura LASIK stands as the pinnacle of laser vision correction today. This advanced procedure, also known as T-CAT (Topography-guided Custom Ablation Treatment), represents the culmination of expertise from leading eye surgeons. By wielding the most powerful tools available, they've refined LASIK techniques to deliver unmatched results. 

In March 2024, Taking LASIK to a new level of precision, wavefront-guided technology creates a personalized map of your eye's imperfections. This detailed map guides the laser to correct these specific errors, including higher-order aberrations, resulting in sharper, more precise vision correction. 

In 2023, Taking LASIK to an even higher level, femtosecond lasers are revolutionizing the procedure. Studies show these lasers create corneal flaps with greater predictability, reducing the risk of complications like corneal abrasions during surgery and unwanted astigmatism afterwards. 

In January 2024, The FDA approved Teneo Excimer Laser Platform (Bausch + Lomb Corporation), a new laser assistance in situ keratomileusis (LASIK), for vision correction surgery for those who have myopia and myopic astigmatism, known as nearsightedness or nearsightedness 

In Mrach 2023, Johnson & Johnson Vision, a part of Johnson & Johnson MedTech, announced that it has received CE Mark approval for its next-generation laser vision correction solution, the ELITA Femtosecond Laser System. The new laser will allow surgeons to perform refractive correction on patients with myopia, with or without astigmatism, via the SILK Procedure, a new lenticular procedure (Smooth Incision Lenticule Keratomileusis).   

In June 2023, ZEISS, a global leader in optics and optoelectronic technology, is delighted to announce the launch of its cutting-edge medical devices, VISUMAX 800 and Quatera 700. 

In October 2022, A research investigation was launched by the Stanford University School of Medicine (United States) to compare the outcomes of wavefront-guided LASIK against topography-guided LASIK in shortsighted persons' randomized contralateral buddy eye examinations.